This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hypothermia
ST19_HYPOTHERMIA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
650 |
4. Check minimum number of eventsNone |
650 |
5. Include endpointsNone |
650 |
6. Filter based on genotype QC (FinnGen only) |
650 |
Control definitions (FinnGen only)
- Control exclude
- ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T6[6-9]|T7[0-8]
- Name in latin
- Hypothermia
Similar endpoints
↥List of similar endpoints to
Hypothermia
based on the number of shared cases.
Similar with more cases:
- Other and unspecified effects of external causes
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 650 | 211 | 439 |
| Unadjusted period prevalence (%) | 0.15 | 0.07 | 0.19 |
| Median age at first event (years) | 61.18 | 59.84 | 61.82 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 569
- Matched controls
- 5689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T68
ICD-10 Finland
Hypothermia
+∞
323.0
569
*
X31
ICD-10 Finland
Exposure to excessive natural cold
447.5
113.8
110
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
10.8
73.6
153
188
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.9
47.4
90
88
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
14.9
45.2
77
59
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.7
44.3
268
1100
N05AH04
ATC
quetiapine; oral
4.7
43.1
171
476
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
15.8
42.2
70
50
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
20.0
38.4
58
32
X59
ICD-10 Finland
Exposure to unspecified factor
4.0
36.3
175
574
N06AX11
ATC
mirtazapine; oral
3.3
35.1
244
1064
AA1AD
NOMESCO Finland
CT of head and brain
3.4
33.9
208
821
F10.09
ICD-10 Finland
Alcohol intoxication UNS
14.6
33.5
57
43
F10.25
ICD-10 Finland
Alcohol dependence continuous use
15.8
31.6
52
36
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.6
31.3
120
312
G72.8
ICD-10 Finland
Other specified myopathies
15.9
31.1
51
35
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
30.5
156
527
P15
ICPC
Chronic alcohol abuse
9.6
29.3
61
70
N05AX08
ATC
risperidone; systemic
4.9
29.1
104
250
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.4
28.8
92
195
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.5
27.9
76
132
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
27.2
208
929
N05AH03
ATC
olanzapine; systemic
5.9
26.1
77
148
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.4
24.9
45
39
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
15.6
23.3
38
26
N07BB01
ATC
disulfiram; oral
6.4
23.1
63
109
N05BA01
ATC
diazepam; systemic, rectal
3.5
22.8
117
388
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
12.6
22.3
40
34
W69
ICD-10 Finland
Drowning and submersion while in natural water
+∞
22.0
21
*
N05CD07
ATC
temazepam; oral
3.3
21.3
123
444
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
21.3
138
541
N03AG01
ATC
valproic acid; systemic, rectal
5.2
21.2
68
144
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
22.5
21.0
30
14
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.3
20.8
51
76
N05AA02
ATC
levomepromazine; systemic
5.9
20.8
60
112
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.1
20.6
67
144
W19
ICD-10 Finland
Unspecified fall
3.9
20.5
92
271
N05BA04
ATC
oxazepam; oral
2.6
19.6
173
815
N06AB04
ATC
citalopram; systemic
2.7
19.0
153
680
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
22.6
18.3
26
12
F10.24
ICD-10 Finland
Alcohol depence active use
12.0
18.2
33
29
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
14.3
17.9
30
22
S01.0
ICD-10 Finland
Open wound of scalp
3.7
17.3
79
236
N05AF03
ATC
chlorprothixene; systemic
8.2
17.1
38
49
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
17.1
74
211
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
12.2
16.2
29
25
P16
ICPC
Acute alcohol abuse
10.5
16.1
31
31
W71
ICD-10 Finland
Drowning to ice
+∞
15.7
15
*
S06.0
ICD-10 Finland
Concussion
3.2
14.9
85
300
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.9
14.8
62
171
X58
ICD-10 Finland
Exposure to other specified factors
2.8
14.7
102
408
X57
ICD-10 Finland
Unspecified privation
7.5
14.2
33
46
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.8
14.1
35
54
Z72.1
ICD-10 Finland
Alcohol use
10.1
13.8
27
28
T33.8
ICD-10 Finland
Superficial frostbite of ankle and foot
+∞
13.6
13
*
W74
ICD-10 Finland
Unspecified drowning and submersion
+∞
13.6
13
*
T51.0
ICD-10 Finland
Toxic effect: Ethanol
35.0
13.6
17
5
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
11.9
13.4
24
21
B18.2
ICD-10 Finland
Chronic viral hepatitis C
11.9
13.4
24
21
N05BA02
ATC
chlordiazepoxide; systemic
5.7
13.2
38
71
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
13.2
105
455
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
15.5
13.2
21
14
N05CF01
ATC
zopiclone; oral
2.0
12.9
201
1197
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
12.4
103
455
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.6
12.4
56
166
Y34
ICD-10 Finland
Unspecified event, undetermined intent
38.4
12.3
15
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.4
12.2
44
106
R53
ICD-10 Finland
Malaise and fatigue
2.3
12.2
135
690
N06AX16
ATC
venlafaxine; oral
2.8
12.1
84
335
N05AX12
ATC
aripiprazole; systemic
5.5
12.0
35
67
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.4
12.0
31
51
SPAT1254
SPAT
Administration of medicine
2.5
11.9
101
453
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
15.1
11.9
19
13
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.4
11.7
42
101
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
11.4
11.6
21
19
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
11.4
11.6
21
19
E86
ICD-10 Finland
Volume depletion
5.8
11.5
32
58
EBA00
NOMESCO Finland
Extraction of tooth
2.0
11.4
195
1191
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.7
11.4
38
85
Z72.2
ICD-10 Finland
Drug use
15.4
11.4
18
12
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.7
11.3
50
145
SPAT1240
SPAT
Therapeutic discussion
3.0
11.1
67
243
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.6
11.1
38
87
N05AD01
ATC
haloperidol; systemic
4.6
11.1
38
87
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
8.8
11.1
23
27
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.7
11.0
76
303
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
4.6
11.0
38
88
ZZA00
NOMESCO Finland
Split skin graft
5.1
11.0
34
70
N06AB03
ATC
fluoxetine; oral
2.7
10.9
80
330
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
9.9
10.8
21
22
N06AB06
ATC
sertraline; oral
2.9
10.8
69
260
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
28.6
10.8
14
5
SPAT1227
SPAT
Substance abuse rehabilitation
13.2
10.7
18
14
R41.0
ICD-10 Finland
Disorientation, unspecified
4.5
10.7
37
86
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
61.1
10.7
12
*
N03AE01
ATC
clonazepam; systemic
3.6
10.6
47
137
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
11.5
10.6
19
17
P29
ICPC
Psychological sympt/compl other
4.0
10.5
42
112
SPAT1234
SPAT
Support of social functional capacity
3.7
10.5
45
128
N05AH02
ATC
clozapine; systemic
7.9
10.5
23
30
F05.9
ICD-10 Finland
Delirium, unspecified
5.7
10.4
29
53
T74.1
ICD-10 Finland
Physical abuse
13.4
10.2
17
13
N05AB03
ATC
perphenazine; systemic, rectal
4.5
10.1
35
82
SPAT1247
SPAT
Outpatient detoxication and monitoring
14.9
10.0
16
11
A28
ICPC
Limited function/disability NOS
2.3
9.8
101
495
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
13.7
9.7
16
12
N05BA06
ATC
lorazepam; systemic, sublingual
3.5
9.7
45
137
X84
ICD-10 Finland
Intentional self-harm by unspecified means
56.0
9.7
11
*
K08.3
ICD-10 Finland
Retained dental root
3.0
9.6
56
201
R40.2
ICD-10 Finland
Coma, unspecified
10.3
9.6
18
18
C03CA01
ATC
furosemide; systemic
1.9
9.6
187
1187
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
7.7
9.5
21
28
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.7
9.5
26
47
X71
ICD-10 Finland
Intentional self-harm by drowning and submersion
101.6
9.4
10
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
30.6
9.4
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
9.4
78
344
SPAT1301
SPAT
No procedures
1.9
9.4
180
1129
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.3
9.4
34
83
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
12.6
9.4
16
13
Y21
ICD-10 Finland
Drowning and submersion, undetermined intent
+∞
9.4
9
*
R68.0
ICD-10 Finland
Hypothermia, not associated with low environmental temperature
+∞
9.4
9
*
WX949
NOMESCO Finland
Warming of hypothermic patient with other methods
+∞
9.4
9
*
F10.59
ICD-10 Finland
Alcohol psychosis, mixed type
+∞
9.4
9
*
E87.2
ICD-10 Finland
Acidosis
22.1
9.4
13
6
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
9.7
9.3
18
19
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.3
9.3
46
147
A41.9
ICD-10 Finland
Sepsis, unspecified
4.1
9.3
35
89
K92.0
ICD-10 Finland
Haematemesis
4.6
9.3
31
70
F60.9
ICD-10 Finland
Personality disorder, unspecified
9.3
9.1
18
20
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
9.0
60
234
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
24.4
8.9
12
5
N05BA12
ATC
alprazolam; oral
2.6
8.8
63
258
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.9
8.7
27
57
R55
ICD-10 Finland
Syncope and collapse
2.4
8.6
75
338
L28
ICPC
Limited function/disability (L)
2.1
8.6
98
504
N03AX16
ATC
pregabalin; oral
2.0
8.6
130
747
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
6.6
8.6
21
33
ZXD05
NOMESCO Finland
Urgent procedure
1.8
8.5
183
1187
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.4
8.4
21
34
A10AE04
ATC
insulin glargine; parenteral
2.4
8.3
71
318
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
8.3
53
203
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
8.3
71
320
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
14.7
8.2
13
9
N06AB10
ATC
escitalopram; oral
2.1
8.2
103
550
W17
ICD-10 Finland
Other fall from one level to another
3.4
8.2
38
116
WX892
NOMESCO Finland
Monitored bed care
2.7
8.2
56
223
N05BE01
ATC
buspirone; oral
4.4
8.1
28
66
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
11.9
8.1
14
12
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.8
8.1
33
91
A06AD11
ATC
lactulose; oral
2.1
8.1
100
532
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
22.4
8.0
11
5
E16.19
ICD-10 Finland
Other specified hypoglycaemia
22.4
8.0
11
5
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.8
8.0
32
87
N06AX05
ATC
trazodone; oral
5.5
7.9
22
41
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
7.9
82
401
WX730
NOMESCO Finland
Conventional respirator
5.9
7.9
21
37
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
3.5
7.9
35
104
P19
ICPC
Drug abuse
11.0
7.8
14
13
P72
ICPC
Schizophrenia
7.1
7.8
18
26
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
9.6
7.8
15
16
N04AA02
ATC
biperiden; systemic
5.2
7.8
23
46
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.6
7.8
57
236
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
7.8
50
192
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.1
7.7
20
34
E87.6
ICD-10 Finland
Hypokalaemia
4.5
7.7
26
60
P20
ICPC
Memory disturbance
2.3
7.7
74
349
SPAT1229
SPAT
Assessment of need for aid
2.8
7.6
49
188
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
25.4
7.6
10
*
W10
ICD-10 Finland
Fall on and from stairs and steps
3.3
7.6
36
113
R11
ICD-10 Finland
Nausea and vomiting
2.6
7.5
52
208
N03AX14
ATC
levetiracetam; systemic
4.5
7.5
25
57
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
7.5
60
260
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
81.1
7.4
8
*
AA400
NOMESCO Finland
Electroconvulsive therapy
13.6
7.4
12
9
N05AN01
ATC
lithium; oral
5.0
7.3
22
45
P99
ICPC
Psychological disorders other
5.0
7.3
22
45
S18
ICPC
Laceration/cut
1.7
7.3
222
1585
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
7.3
7
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
7.3
67
311
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
7.3
157
1014
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
7.2
41
144
N05CF02
ATC
zolpidem; oral
2.0
7.2
94
510
V03AA01
ATC
NA
5.1
7.2
21
42
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
7.2
64
294
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
6.7
7.2
17
26
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
7.2
163
1070
TK800
NOMESCO Finland
Hemodialysis
4.8
7.1
22
47
S01.9
ICD-10 Finland
Open wound of head, part unspecified
5.3
7.0
20
39
E87.5
ICD-10 Finland
Hyperkalaemia
5.3
7.0
20
39
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
7.0
76
380
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
14.0
6.9
11
8
S97
ICPC
Chronic ulcer skin
2.9
6.9
40
144
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
6.9
82
430
SPAT1252
SPAT
Overall medication plan or its review
2.7
6.8
45
176
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
11.1
6.8
12
11
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
6.8
35
117
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
40.5
6.8
8
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
22.8
6.7
9
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.3
6.7
23
55
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.4
6.7
56
250
SPAT1216
SPAT
Assessment of functional ability
2.0
6.7
86
463
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
12.4
6.6
11
9
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
12.4
6.6
11
9
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.4
6.6
22
51
Y94.0
ICD-10 Finland
Accident at home
5.1
6.5
19
38
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
5.4
6.5
18
34
A46
ICD-10 Finland
Erysipelas
1.9
6.5
92
512
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
7.5
6.4
14
19
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
70.6
6.4
7
*
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
14.5
6.4
10
7
N03AX09
ATC
lamotrigine; oral
3.3
6.4
30
94
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
6.4
95
541
K70.1
ICD-10 Finland
Alcoholic hepatitis
8.3
6.4
13
16
SPAT1307
SPAT
Psychosocial counselling and guidance
3.1
6.3
33
112
XA400
NOMESCO Finland
EEG
11.2
6.3
11
10
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
6.3
42
166
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
9.4
6.3
12
13
J69.8
ICD-10 Finland
Pneumonitis due to other solids and liquids
18.2
6.3
9
5
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
+∞
6.3
6
*
2913A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal hallucinosis
+∞
6.3
6
*
T34.8
ICD-10 Finland
Frostbite with tissue necrosis of ankle and foot
+∞
6.3
6
*
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
3.7
6.3
25
69
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
6.2
45
187
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
6.2
102
601
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
6.4
6.2
15
24
N06AA12
ATC
doxepin; systemic
2.9
6.2
36
131
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.1
6.1
31
103
N06AB05
ATC
paroxetine; oral
2.8
6.1
36
132
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.7
6.1
10
8
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
12.7
6.1
10
8
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
8.7
6.1
12
14
S01
ICD-10 Finland
Open wound of head
6.1
6.0
15
25
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
5.6
6.0
16
29
I95.9
ICD-10 Finland
Hypotension, unspecified
5.6
6.0
16
29
M79.6
ICD-10 Finland
Pain in limb
1.6
6.0
169
1168
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020191) Ethanol [Moles/volume] in Serum or Plasma
54
40
14.63
58.55
1.9
1.4
promille
1.6
1.2
0.52
37
32
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
320
1534
3.14
44.85
3.6
2.1
u/l
658.3
279.2
3.46
304
1439
(3028707) Methadone [Presence] in Urine by Screen method
56
71
8.54
41.93
4.5
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
59
105
6.08
32.34
6.5
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
159
624
3.05
29.89
8.4
8.7
mmol/l
1.5
1.1
0.34
118
497
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
157
622
3.01
28.94
3.2
1.8
%
1.7
1.5
2.27
132
538
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
158
630
2.99
28.78
8.5
8.6
kpa
5.2
5.1
0.16
149
601
(3027801) Oxygen [Partial pressure] in Arterial blood
158
631
2.99
28.69
8.5
8.6
kpa
11.3
11.8
0.62
149
605
(3016502) Oxygen saturation in Arterial blood
148
571
3.06
28.56
8.5
9.0
%
95.3
95.2
0.03
139
553
(3023183) Ammonium ion [Moles/volume] in Plasma
65
142
4.97
28.43
2.0
3.6
umol/l
33.1
35.0
0.22
54
119
(3023368) Bacteria identified in Blood by Culture
279
1534
2.43
26.22
4.6
4.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
58
124
5.04
25.98
4.3
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
63
152
4.48
24.36
4.8
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
105
363
3.26
24.17
7.5
6.0
—
—
—
0
0
(4198724)
24
21
11.83
23.24
2.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
63
162
4.20
22.41
4.8
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
100
352
3.18
22.27
12.0
8.2
mmol/l
23.3
24.2
0.85
94
328
(3028300) Cannabinoids [Presence] in Urine
63
164
4.15
22.05
4.8
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
62
164
4.07
21.22
4.8
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
24
25
9.93
20.66
2.1
1.5
umol/l
74.3
66.4
—
10
13
(3027944) Amphetamines [Presence] in Urine
61
164
4.00
20.41
4.7
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
119
498
2.70
19.22
5.3
4.0
kpa
5.9
5.8
0.22
113
485
(3003458) Phosphate [Moles/volume] in Serum or Plasma
146
680
2.48
18.89
6.5
6.3
mmol/l
1.0
1.0
0.17
138
632
(3002032) Base excess in Venous blood by calculation
118
497
2.68
18.79
5.4
4.0
mmol/l
1.5
1.9
0.43
93
399
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
342
2262
2.08
18.48
9.4
6.5
mmol/l
1.2
1.2
9.59
310
2052
(3014111) Lactate [Moles/volume] in Serum or Plasma
116
494
2.64
18.03
7.5
7.5
mmol/l
1.8
1.4
1.06
110
470
(3024354) Oxygen [Partial pressure] in Venous blood
104
426
2.72
17.43
4.6
3.1
kpa
4.8
4.4
0.87
97
411
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
359
2462
2.02
17.06
9.5
7.4
mmol/l
1.2
1.2
5.53
301
2070
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
258
1586
2.04
16.54
3.6
2.6
u/l
56.7
56.8
0.01
240
1489
(3012095) Magnesium [Moles/volume] in Serum or Plasma
160
830
2.23
15.90
3.2
3.8
mmol/l
0.8
0.8
0.10
149
781
(3009466) Valproate [Moles/volume] in Serum or Plasma
36
81
4.65
15.12
6.2
5.0
umol/l
363.6
364.6
0.01
31
72
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
24
37
6.70
15.01
26.2
18.3
nmol/l
1410.7
1477.7
0.12
24
37
(3020779) Urea [Moles/volume] in Serum or Plasma
105
469
2.48
14.63
8.1
8.2
mmol/l
11.6
10.5
0.66
98
443
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
370
2673
1.89
13.96
6.2
6.6
umol/l
10.7
12.2
2.55
348
2541
(3032080) INR in Blood by Coagulation assay
316
2180
1.87
13.68
10.9
10.7
inr
1.3
1.3
0.53
99
632
(3013826) Glucose [Moles/volume] in Serum or Plasma
403
3024
1.88
13.16
8.8
5.2
mmol/l
7.4
6.8
3.55
386
2828
(3020891) Body temperature
59
207
3.03
13.06
11.3
4.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
300
2058
1.85
13.03
5.4
3.8
ng/l
163.9
49.7
0.45
235
1494
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
161
902
2.04
12.82
2.0
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
313
2189
1.83
12.66
5.2
5.0
g/l
33.2
35.3
6.14
285
2045
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
252
1653
1.86
12.50
4.0
3.4
u/l
39.4
34.0
0.99
240
1571
(3019309) Folate [Moles/volume] in Red Blood Cells
173
1003
1.99
12.47
2.1
1.7
nmol/l
1273.4
1190.7
0.45
130
764
(3000991) Gas panel - Venous blood
98
455
2.36
12.45
9.4
9.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
231
1476
1.88
12.44
4.8
4.2
ph
7.4
7.4
0.27
47
294
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
30
6.49
11.60
2.5
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
132
717
2.06
11.31
26.3
24.7
inr
1.4
1.4
0.06
19
98
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
290
2036
1.77
11.14
2.3
2.0
pmol/l
94.0
93.9
0.01
160
1096
(3021901) Oxygen saturation in Capillary blood
37
108
3.57
11.00
3.0
2.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
39
121
3.37
10.57
4.8
3.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
37
112
3.44
10.42
3.1
2.6
%
15.2
15.7
0.19
20
56
(3014576) Chloride [Moles/volume] in Serum or Plasma
125
687
2.01
10.30
10.5
7.3
mmol/l
104.0
104.3
0.17
120
671
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
117
631
2.04
10.15
1.9
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
117
635
2.03
9.97
1.9
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
19
7.51
9.73
1.4
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
94
475
2.14
9.67
3.3
2.7
ug/l
5.9
8.2
0.88
82
424
(3027945) Reticulocytes/100 erythrocytes in Blood
113
615
2.01
9.53
1.7
2.6
%
1.8
1.8
0.03
99
549
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
66
289
2.43
9.51
9.9
12.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
43
152
2.96
9.41
3.1
2.4
mmol/l
25.0
24.5
0.21
38
128
(3015377) Calcium [Moles/volume] in Serum or Plasma
235
1614
1.71
9.36
2.8
3.4
mmol/l
2.3
2.3
1.86
201
1422
(3022948) Iron [Moles/volume] in Serum or Plasma
138
809
1.90
9.36
3.1
2.4
umol/l
11.0
12.8
1.83
125
748
(3010421) pH of Blood
43
153
2.94
9.30
5.4
4.0
ph
7.4
7.4
0.54
35
125
(3019150) Specific gravity of Urine by Refractometry
171
1074
1.80
9.30
5.8
3.9
kg/l
1.0
1.0
0.28
27
161
(3026008) Bacteria identified in Urine by Culture
215
1450
1.72
9.10
4.2
3.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
115
3.16
8.67
2.5
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
37
126
3.05
8.64
5.1
4.1
mmol/l
2.7
2.4
0.30
23
83
(3018677) aPTT in Platelet poor plasma by Coagulation assay
138
830
1.84
8.58
2.0
2.2
s
30.2
29.7
0.46
131
805
(3047181) Lactate [Moles/volume] in Blood
44
167
2.75
8.47
6.9
9.3
mmol/l
1.9
1.3
1.09
37
145
(3009508) Creatinine [Moles/volume] in Urine
226
1570
1.67
8.45
4.4
3.2
mmol/l
6.3
8.1
9.02
198
1310
(40758558) Short blood count panel - Blood
183
1201
1.73
8.44
7.3
7.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
62
279
2.35
8.41
8.8
10.9
mmol/l
23.8
24.5
0.75
56
258
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
57
247
2.43
8.40
1.9
2.0
ug/l
1.1
2.6
0.67
49
217
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
157
991
1.77
8.29
5.0
4.0
ng/l
110.6
347.1
2.67
134
814
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
1077
1.73
7.92
1.8
1.8
pmol/l
399.6
10887071.2
0.79
139
891
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
8
15.25
7.74
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
56
251
2.35
7.67
4.9
4.1
mmol/l
23.5
24.1
0.66
48
226
(3004789) Transferrin [Mass/volume] in Serum or Plasma
125
754
1.81
7.63
3.1
2.4
g/l
2.2
2.3
0.36
114
697
(3044640) Blood type and Crossmatch panel - Blood
225
1597
1.63
7.56
2.7
2.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
109
634
1.86
7.47
2.2
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
72
363
2.11
7.42
3.1
3.6
ph
7.4
7.4
0.84
16
45
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
73
370
2.10
7.42
3.1
3.6
kpa
5.2
5.1
0.36
68
342
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
255
1877
1.59
7.31
3.9
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
117
705
1.80
7.15
3.3
2.4
%
21.0
22.9
0.59
96
612
(3036481) Cortisol [Moles/volume] in Serum or Plasma
83
450
1.97
7.01
1.8
1.9
nmol/l
479.5
372.6
0.62
75
411
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
88
489
1.92
6.92
2.0
2.3
g/l
0.2
0.2
2.76
76
454
(3023520) Reticulocytes [#/volume] in Blood
83
455
1.94
6.79
2.0
2.8
e9/l
69.1
69.7
0.05
71
360
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
67
340
2.08
6.79
3.2
3.7
mmol/l
1.4
1.8
0.26
49
254
(40761535) Cells panel - Urine sediment
78
419
1.98
6.77
4.2
3.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
96
556
1.85
6.65
4.9
3.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
453
3848
1.58
6.63
8.3
7.8
u/l
82.5
79.3
0.74
426
3617
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
185
1286
1.61
6.62
2.4
2.1
mg/l
3.4
3.1
0.58
159
1092
(3031040) Bacteria [#/volume] in Urine by Automated count
396
3264
1.55
6.62
6.0
4.4
e6/l
3996.2
2757.4
—
10
63
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
79
438
1.91
6.25
3.9
3.2
ng/l
232.5
246.4
0.11
74
399
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
63
328
2.02
5.97
1.6
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
160
1103
1.60
5.84
3.5
2.6
e6/l
6.1
4.8
0.64
149
972
(3011397) Hemoglobin [Presence] in Urine by Test strip
156
1076
1.59
5.67
4.8
3.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
170
1208
1.55
5.40
1.7
1.6
nmol/l
19.0
20.0
0.42
146
1019
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
382
1.87
5.18
2.0
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
179
1301
1.52
5.09
5.6
4.0
estimate
0.0
0.0
0.69
49
447
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
80
477
1.77
5.03
2.7
2.4
u/l
927.8
33.8
0.49
67
408
(3013650) Neutrophils [#/volume] in Blood by Automated count
345
2856
1.44
5.02
10.8
9.5
e9/l
4.7
4.2
2.40
299
2526
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
288
2307
1.45
4.99
4.7
4.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
313
2555
1.43
4.86
6.5
6.2
e9/l
0.2
0.2
0.04
270
2270
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
387
3286
1.44
4.82
5.4
3.2
u/l
64.7
54.1
1.07
357
3075
(3002582) Erythrocytes [#/volume] in Urine
210
1593
1.47
4.80
3.9
3.4
e6/l
207.0
104.9
0.25
178
1246
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
133
916
1.57
4.80
2.7
3.2
mmol/l
2.4
2.4
0.01
110
802
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
326
1.89
4.73
1.6
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
93
593
1.66
4.59
13.6
7.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
309
2538
1.41
4.53
6.2
5.9
e9/l
2.1
2.0
0.02
270
2256
(3001604) Monocytes [#/volume] in Blood
302
2473
1.41
4.49
6.1
5.9
e9/l
0.6
0.6
0.98
260
2156
(3003181) Sodium [Moles/volume] in Urine
24
94
2.61
4.43
1.5
1.3
mmol/l
73.6
63.1
0.33
16
80
(3033658) Prothrombin time (PT) actual/Normal
170
1256
1.48
4.39
5.2
4.1
%
86.0
86.9
0.17
164
1231
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
404
3493
1.41
4.32
4.2
3.5
pmol/l
14.6
14.9
1.26
358
3126
(42870588) Differential panel, method unspecified - Blood
216
1675
1.43
4.32
5.7
5.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
302
2485
1.40
4.31
6.2
5.9
e9/l
0.0
0.0
0.98
261
2175
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
159
2.20
4.29
1.7
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
238
1881
1.42
4.27
2.5
2.2
nmol/l
69.4
76.1
2.82
204
1664
(3020682) Albumin/Creatinine [Ratio] in Urine
203
1561
1.44
4.24
4.5
4.0
mg/mmol
16.2
10.6
0.65
143
1031
(3030467) Casts [#/volume] in Urine by Automated count
190
1444
1.45
4.22
3.7
3.3
e6/l
0.8
0.5
0.63
157
1095
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
115
2.41
4.21
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
115
2.41
4.21
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
94
615
1.62
4.19
2.2
2.9
umol/l
14.0
9.6
0.48
79
543
(21494755) Public health laboratory ask at order entry panel
18
448
0.38
4.16
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
110
2.42
4.12
3.2
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
243
1.92
3.90
1.5
1.9
g/l
1.5
1.5
0.03
39
210
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
235
1878
1.39
3.88
5.5
3.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
226
1801
1.39
3.78
4.4
3.8
e6/l
137.7
143.1
0.03
180
1322
(1761868) Lipid panel - Serum or Plasma
129
1735
0.68
3.74
3.1
2.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
180
1385
1.41
3.67
3.6
3.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
551
5108
1.52
3.58
30.8
18.1
mmol/l
139.0
139.6
4.04
536
4968
(3037467) Urinalysis macro (dipstick) panel - Urine
387
3382
1.36
3.52
5.2
4.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
286
2389
1.35
3.49
6.4
5.0
estimate
0.0
0.0
0.00
55
470
(3009261) Glucose [Presence] in Urine by Test strip
289
2419
1.35
3.48
5.0
3.7
estimate
0.0
0.0
0.50
53
444
(3035350) Ketones [Presence] in Urine by Test strip
286
2391
1.35
3.47
5.0
3.7
estimate
0.0
0.0
0.00
53
464
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
10
7.06
3.37
2.3
1.9
umol/l
15.4
14.8
—
7
10
(3012516) Albumin [Mass/volume] in Urine
187
1468
1.38
3.36
3.6
3.3
mg/l
83.0
267.9
1.32
137
995
(3023103) Potassium [Moles/volume] in Serum or Plasma
551
5126
1.49
3.33
30.3
18.2
mmol/l
4.0
4.0
0.81
538
4984
(3001122) Ferritin [Mass/volume] in Serum or Plasma
247
2031
1.35
3.30
3.5
2.6
ug/l
141.3
160.8
0.77
223
1856
(3021589) Normoblasts [#/volume] in Blood
260
2160
1.34
3.23
12.4
10.1
e9/l
0.0
0.0
0.11
211
1787
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
536
4969
1.45
3.21
25.5
15.4
mg/l
26.2
26.2
0.01
478
3996
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
140
1057
1.41
3.14
1.6
1.8
mg/l
1.6
1.3
0.39
108
821
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
393
0.44
3.07
1.5
1.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
16
5.05
3.06
1.8
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
16
5.05
3.06
1.8
3.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
282
2394
1.31
2.94
6.6
6.1
%
26.0
27.0
0.73
254
2255
(3026782) Osmolality of Urine
138
1051
1.40
2.94
3.4
2.9
mosm/kgh2o
525.2
577.3
1.90
121
895
(3019069) Monocytes/100 leukocytes in Blood
276
2346
1.31
2.82
6.5
6.3
%
8.6
8.9
0.77
252
2223
(3017509) Phencyclidine [Presence] in Urine
5
6
8.39
2.75
3.8
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
107
788
1.43
2.75
2.7
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
199
1622
1.33
2.73
3.4
3.2
ng/l
2077.6
1664.3
0.68
168
1400
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
474
4345
1.34
2.72
5.3
4.3
mu/l
6.7
2.2
0.50
424
3925
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
371
1.59
2.64
4.3
3.8
ng/l
108.3
84.2
0.87
46
328
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
59
389
1.57
2.59
3.4
2.8
ml/min/173m2
51.5
65.9
1.35
20
169
(3006504) Eosinophils/100 leukocytes in Blood
273
2337
1.29
2.58
6.3
6.0
%
2.6
2.9
0.79
247
2201
(3022096) Basophils/100 leukocytes in Blood
266
2277
1.28
2.50
6.4
6.0
%
0.5
0.6
2.36
241
2146
(3018010) Neutrophils/100 leukocytes in Blood
274
2357
1.28
2.47
6.7
5.9
%
58.8
57.7
0.67
250
2228
(3022313) Gas panel - Capillary blood
43
266
1.66
2.45
2.9
3.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
28
153
1.87
2.42
2.9
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
153
1222
1.33
2.39
2.8
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
50
324
1.59
2.38
4.5
2.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
8
6.29
2.37
5.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
111
1424
0.73
2.30
2.4
3.1
ug/l
0.7
0.8
0.19
69
937
(3030981) Hyaline casts [#/volume] in Urine by Automated count
46
295
1.60
2.29
3.2
2.8
e6/l
0.4
0.3
0.37
46
288
(3017143) Hepatitis C virus Ab [Presence] in Serum
79
570
1.44
2.28
1.8
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
149
1827
0.76
2.25
2.4
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
157
1.82
2.25
1.8
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
93
2.07
2.23
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
113
872
1.36
2.21
2.8
2.9
e6/l
1.3
1.0
0.46
78
511
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
87
2.10
2.19
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
263
0.45
2.13
1.5
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
68
2.23
2.12
1.8
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
37
2.73
2.11
1.6
2.8
%
9.0
11.1
—
10
37
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
177
1.73
2.06
2.6
2.8
u/ml
0.4
0.3
0.14
18
92
(4035726)
26
435
0.58
2.01
1.6
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
57
2.31
1.98
2.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
167
1989
0.78
1.97
4.4
4.3
%
21.4
21.1
0.10
73
949
(3020630) Protein [Mass/volume] in Serum or Plasma
60
425
1.45
1.93
1.7
2.9
g/l
62.5
66.3
2.24
50
393
(3044290) Cell count panel - Cerebral spinal fluid
17
85
2.03
1.91
1.2
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
156
0.38
1.91
1.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
51
0.00
1.89
0.0
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
38
245
1.59
1.89
2.9
3.4
pmol/l
4.1
4.6
1.41
31
214
(3016018) Differential panel - Cerebral spinal fluid
10
40
2.52
1.84
1.1
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
130
1.80
1.84
1.6
1.4
ug/g
194.9
276.4
1.04
14
76
(3001019) Free T4 and TSH panel - Serum or Plasma
7
167
0.41
1.81
1.3
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
29
2.78
1.79
1.4
2.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
57
407
1.44
1.77
5.5
4.0
mmol/l
1.2
1.2
2.91
47
361
(3023199) Leukocytes [#/volume] in Pleural fluid
15
74
2.05
1.76
1.9
1.3
e6/l
1143.4
1444.8
—
9
49
(3000093) Morphology [Interpretation] in Blood Narrative
10
41
2.46
1.76
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
81
2.00
1.76
1.3
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
119
958
1.30
1.75
1.4
1.2
u/ml
1.0
1.8
0.81
33
267
(3013512) EKG study
176
1492
1.25
1.69
4.4
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
58
421
1.41
1.66
4.6
3.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
25
2.82
1.65
1.1
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
105
1.83
1.64
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
49
2.27
1.64
1.2
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
77
1.97
1.60
1.2
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
32
2.52
1.60
1.5
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
92
1.87
1.57
1.2
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
137
1.70
1.57
1.6
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
19
107
1.80
1.56
1.9
1.8
nmol/l
0.4
0.9
2.66
14
88
(3023511) Choriogonadotropin [Units/volume] in Urine
11
51
2.18
1.51
2.5
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
437
4088
1.21
1.50
28.2
18.8
%
14.2
13.7
4.21
427
4005
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.2
1.8
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
23
2.62
1.37
1.3
1.3
%
0.8
1.6
—
6
15
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
83
1.83
1.32
4.5
3.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
24
2.51
1.30
1.3
1.4
%
37.2
59.7
—
6
15
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
130
1097
1.23
1.30
4.4
4.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
69
1.90
1.29
1.9
1.2
e6/l
4418.3
40374.9
—
6
36
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
55
2.02
1.28
2.4
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
236
1.47
1.27
2.6
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
45
2.01
1.23
1.2
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
383
0.67
1.23
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
109
1295
0.81
1.22
1.5
1.7
mmol/l
1.4
1.4
0.00
88
1084
(40761511) CBC panel - Blood by Automated count
536
5152
1.23
1.22
24.7
14.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
78
1.81
1.22
1.1
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
37
2.18
1.21
1.4
3.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
37
2.18
1.21
1.4
3.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
71
1.85
1.20
1.3
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.3
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.3
1.9
—
—
—
0
0
(3035880) pH of Pleural fluid
8
38
2.12
1.18
1.5
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.2
—
0.1
—
0
18
(40768806) Pleura Pathology biopsy report
13
72
1.82
1.15
1.5
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
134
1.59
1.15
1.1
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
20
2.51
1.15
1.2
1.1
%
46.2
28.3
—
5
15
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
224
2477
0.85
1.13
4.4
5.0
ug/l
6.2
2.5
0.64
183
2204
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
128
1.58
1.09
1.2
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
610
0.75
1.09
4.4
4.5
%
29.4
31.2
0.52
27
414
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
548
5295
1.22
1.08
12.7
10.5
u/l
29.2
27.7
0.78
528
5115
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
203
1.45
1.07
2.1
3.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
36
263
1.39
1.06
3.4
4.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
46
1.97
1.04
1.1
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
7
34
2.07
1.03
1.0
1.0
ng/l
305.4
245.2
—
7
18
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
7
34
2.07
1.03
1.0
1.0
ng/l
817.0
513.0
—
7
18
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
7
34
2.07
1.03
1.0
1.0
ng/l
32.6
35.6
—
7
16
(1761482) Bacteria [#/volume] in Urine by Culture
23
156
1.49
1.00
4.3
5.1
—
—
—
0
0
(3019225) pH of Specimen
59
471
1.28
0.98
5.9
4.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
34
250
1.38
0.98
2.1
2.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
100
1.62
0.97
1.2
1.5
e6/l
2.5
1198.0
0.56
11
80
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
100
1.62
0.97
1.1
1.4
e6/l
0.8
14.6
—
10
77
(3014271) Vancomycin [Susceptibility]
7
37
1.90
0.94
4.3
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
27
2.23
0.93
1.2
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
142
1.49
0.93
1.3
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
126
1.52
0.92
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
193
1.42
0.92
1.9
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
28
2.15
0.91
3.8
2.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
439
4189
1.15
0.90
33.7
19.7
g/l
332.3
333.4
1.46
433
4158
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
9
154
0.58
0.89
1.8
2.5
u/ml
65.6
51.9
—
9
146
(3023419) Bacteria identified in Sputum by Culture
13
79
1.66
0.88
1.3
2.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
87
1.62
0.88
1.7
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
96
1.58
0.85
1.1
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
369
3491
1.13
0.83
5.0
4.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
105
1.54
0.82
2.2
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
73
1.66
0.82
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
71
594
1.22
0.81
1.4
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
16
106
1.52
0.79
3.6
2.8
nmol/l
0.7
0.9
—
10
85
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
34
1.77
0.76
1.0
1.2
—
24.0
—
0
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.3
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
10
59
1.71
0.76
1.2
1.3
mmol/l
7.2
7.4
—
10
40
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
124
1.46
0.75
1.2
1.4
miu/ml
242.6
238.9
—
5
56
(3013707) Erythrocyte sedimentation rate by Westergren method
378
3595
1.12
0.75
4.0
4.0
mm/h
15.3
12.4
2.33
341
3295
(4034850)
22
158
1.41
0.75
8.4
11.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
54
1.68
0.74
3.1
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
96
834
1.18
0.74
3.1
3.1
e6/l
3.2
1.7
0.78
63
478
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
135
0.59
0.74
1.3
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
142
1.42
0.73
2.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
39
1.80
0.72
7.6
2.0
—
—
—
0
0
(1002224) Polysomnography panel
13
194
0.66
0.72
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
57
1.59
0.71
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
55
456
1.23
0.70
1.7
1.4
—
—
—
0
0
(4010399)
41
329
1.26
0.69
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
69
1.60
0.68
2.6
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
144
1.40
0.68
2.0
1.2
—
—
—
0
0
(4094501)
7
120
0.58
0.68
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
405
0.78
0.67
2.0
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
7
43
1.63
0.67
4.0
2.0
umol/l
6.7
9.6
—
7
29
(42529406) Shigella sp [Presence] in Stool by Culture
20
145
1.39
0.66
2.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
111
1.45
0.66
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
44
1.60
0.65
1.4
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
102
0.58
0.62
1.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
50
1.61
0.61
1.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
50
1.61
0.61
1.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
50
1.61
0.61
1.0
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
20
0.00
0.60
0.0
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
20
0.00
0.60
0.0
3.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
80
1.51
0.60
1.9
2.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
71
615
1.17
0.59
2.7
4.3
u/l
247.7
248.9
0.03
65
577
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
14.8
—
0
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
101
900
1.14
0.58
1.5
1.4
g/l
2.6
2.6
0.03
54
575
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
663
1.17
0.58
1.9
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
347
1.22
0.58
1.5
2.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
89
0.56
0.56
1.6
2.9
u/ml
3.4
49.4
—
5
83
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
37
1.63
0.55
3.0
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
317
0.78
0.55
2.3
2.4
—
10.9
—
0
16
(36660697) Celiac disease serology panel - Serum
40
331
1.22
0.55
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
73
639
1.16
0.54
1.4
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
60
1.51
0.54
1.2
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
91
811
1.14
0.53
2.1
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
563
5525
1.14
0.53
36.3
22.2
e9/l
245.1
240.7
0.75
545
5378
(3024731) MCV [Entitic volume]
563
5526
1.14
0.52
36.1
22.1
fl
91.6
91.2
1.52
550
5436
(3035941) MCH [Entitic mass]
563
5527
1.14
0.52
36.1
22.1
pg
30.5
30.4
0.34
550
5436
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.0
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
563
5528
1.14
0.51
36.2
22.2
e12/l
4.3
4.5
13.16
544
5361
(3000963) Hemoglobin [Mass/volume] in Blood
563
5529
1.14
0.50
36.7
22.3
g/l
131.5
136.9
11.29
549
5434
(3010813) Leukocytes [#/volume] in Blood
563
5529
1.14
0.50
36.3
22.3
e9/l
7.5
6.9
3.57
541
5363
(3026389) Candida sp identified in Specimen by Organism specific culture
7
47
1.49
0.47
1.1
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
102
1.38
0.47
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
94
1.39
0.46
1.0
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
306
2933
1.08
0.44
2.8
2.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
211
1.24
0.44
2.5
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
475
4639
1.09
0.42
21.3
14.2
ml/min/173m2
80.5
79.9
0.19
388
3847
(40768443) Skin Pathology biopsy report
16
206
0.77
0.42
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.8
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
33
1.52
0.41
1.8
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
15
0.00
0.41
0.0
1.4
—
112.9
—
0
10
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
16
0.00
0.41
0.0
1.1
—
393.1
—
0
7
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
132
1.30
0.40
1.2
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
1.4
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
60
1.34
0.40
1.0
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
9.7
—
0
18
(40765096) Chromosome analysis panel by Banding
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
461
4504
1.08
0.38
25.1
16.4
%
38.2
40.2
3.17
269
3177
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
36
1.39
0.38
1.4
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
67
1.35
0.38
1.4
2.4
pg
32.1
33.3
—
9
67
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
502
0.87
0.37
1.4
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
77
0.65
0.36
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
123
0.73
0.35
1.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
167
0.77
0.34
2.0
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
188
0.79
0.33
3.7
3.7
g/l
0.2
0.2
—
6
88
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
210
1.20
0.33
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
164
1.23
0.33
1.5
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
74
676
1.11
0.32
1.3
1.3
u/ml
1.1
13.5
4.34
23
266
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.7
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
24
283
0.84
0.31
1.1
1.3
—
19.3
—
0
15
(3025159) Blasts/100 leukocytes in Blood
32
367
0.87
0.30
4.0
4.6
%
0.0
0.1
—
7
108
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
102
1.28
0.30
3.1
2.5
u/l
1462.3
931.8
—
5
40
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
57
1.23
0.29
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
151
0.79
0.28
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
261
1.16
0.28
1.1
1.2
iu/ml
141.6
152.7
—
6
102
(44790048)
8
63
1.27
0.28
1.3
1.6
—
—
—
0
0
(44790047)
8
63
1.27
0.28
1.3
1.6
—
—
—
0
0
(44790049)
8
63
1.27
0.28
1.3
1.6
—
—
—
0
0
(44806118)
8
63
1.27
0.28
1.3
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
464
4558
1.06
0.27
7.8
5.9
mmol/mol
42.7
40.3
3.76
428
4238
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
116
0.77
0.27
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
150
1.21
0.26
2.4
2.5
ug/min
102.6
99.4
0.03
12
92
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
17
142
1.20
0.25
1.8
3.2
g/l
3.7
3.7
0.05
17
132
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
137
0.80
0.24
1.3
2.2
mg/l
9.9
11.8
0.40
11
127
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
78
1.29
0.24
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
13
158
0.82
0.24
1.3
1.6
iu/ml
6.7
0.0
—
6
36
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
106
1.23
0.23
1.2
1.2
u/ml
241.8
284.7
—
6
59
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
181
1.17
0.22
1.0
3.1
g/l
3.0
3.1
0.32
14
143
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(4281824)
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.2
—
2.6
—
0
5
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
2.5
—
7703.5
—
0
10
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.0
—
7.5
—
0
12
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
365
1.10
0.20
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
52
1.16
0.19
3.2
2.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
100
1.20
0.18
2.2
3.1
e9/l
4.6
4.5
0.09
12
100
(3051611) Lipemic interference index of Serum or Plasma
7
60
1.17
0.18
3.0
3.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
195
1.13
0.17
1.9
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
142
0.84
0.17
1.5
1.9
pmol/l
205.6
230.4
0.31
12
133
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
75
710
1.06
0.17
1.3
1.2
iu/ml
14.0
36.1
4.55
23
229
(3025941) Bacteria identified in Stool by Culture
29
263
1.11
0.16
1.8
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
215
1.12
0.16
1.9
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
391
0.92
0.16
3.9
4.6
%
0.4
0.2
0.58
11
129
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
119
0.84
0.15
1.3
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
49
523
0.93
0.15
2.1
2.2
nmol/l
12.6
13.7
0.40
40
469
(3042631) Mycobacterium sp identified in Specimen
9
82
1.10
0.15
2.6
3.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
131
1.15
0.14
1.1
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
112
1.16
0.14
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
43
402
1.07
0.14
1.6
2.4
g/l
10.3
11.0
0.32
38
365
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
484
4794
1.04
0.14
5.0
4.5
mmol/l
6.4
6.0
2.13
427
4335
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
104
1.16
0.12
2.2
3.6
%
62.1
58.1
0.44
12
104
(3048689) Calprotectin [Mass/mass] in Stool
56
532
1.06
0.12
1.8
2.3
ug/g
168.9
125.2
0.46
45
434
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
191
1.10
0.12
1.8
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
191
1.10
0.12
1.0
3.0
g/l
3.8
3.8
0.05
14
140
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
16
143
1.12
0.11
1.8
3.0
%
71.3
87.6
1.62
16
136
(3017732) Neutrophils [#/volume] in Blood
30
322
0.93
0.11
4.7
2.5
e9/l
4.6
4.1
0.29
21
251
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
46
436
1.06
0.11
1.8
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
192
1.10
0.11
1.0
3.0
g/l
7.5
7.2
0.28
14
146
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
192
1.10
0.11
1.0
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
139
1355
1.03
0.10
4.7
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
154
1.11
0.10
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
44
1.14
0.10
1.2
3.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
18
164
1.10
0.10
1.8
4.3
mg/l
48.6
103.1
0.71
11
133
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
18
164
1.10
0.10
1.8
4.3
mg/l
58.4
37.6
0.36
11
134
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
54
1.11
0.09
1.3
2.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
139
1361
1.03
0.08
2.7
2.8
umol/l
387.1
7634.1
5.91
107
1180
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
62
0.80
0.08
1.0
1.2
nmol/l
0.4
0.6
—
5
55
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
469
4659
1.02
0.08
4.0
4.0
mmol/l
1.4
1.3
1.27
415
4249
(3037522) Nuclear Ab [Titer] in Serum
63
608
1.04
0.08
1.4
1.3
titre
603.6
373.3
0.48
11
117
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
64
1.09
0.08
1.1
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
195
0.92
0.08
1.7
1.8
nmol/l
45.7
39.9
0.52
18
186
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
65
1.08
0.08
1.3
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
65
1.08
0.08
1.3
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
66
1.06
0.08
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
66
1.06
0.08
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
66
1.06
0.08
1.3
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
70
0.86
0.07
1.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
392
1.05
0.07
1.8
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
75
0.80
0.07
1.2
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
276
0.94
0.07
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
82
0.85
0.07
1.1
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
17
157
1.09
0.07
1.1
3.2
g/l
36.2
37.6
0.36
12
134
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
177
1.08
0.06
1.1
3.1
g/l
9.9
10.6
0.24
14
152
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
552
1.04
0.06
3.2
4.4
ug/l
11.3
30.4
0.66
51
464
(3022145) Colonoscopy Study observation
52
536
0.97
0.05
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
374
0.96
0.05
2.9
4.4
%
0.4
0.5
—
5
104
(40760888) Immunoglobulin light chains.free panel - Serum
11
120
0.92
0.05
2.2
4.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
480
4819
0.98
0.04
4.3
4.4
mmol/l
1.3
1.4
1.65
431
4407
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
91
1.10
0.04
1.4
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
12
129
0.93
0.03
2.1
3.4
%
191.7
189.6
0.03
12
124
(3017181) Myelocytes/100 leukocytes in Blood
43
419
1.03
0.03
3.5
4.5
%
1.6
0.9
0.30
14
143
(3009445) Proteinase 3 Ab [Units/volume] in Serum
23
221
1.04
0.03
1.0
1.5
—
10.1
—
0
5
(3003694) ABO and Rh group [Type] in Blood
133
1343
0.99
0.02
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
122
1.07
0.02
3.6
4.0
mg/l
18.5
25.9
—
8
84
(3002256) Pathology report gross observation
62
610
1.02
0.02
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
70
690
1.02
0.02
1.4
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
21
202
1.04
0.02
1.2
1.1
—
135.2
—
0
6
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
107
0.93
0.02
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
36
353
1.02
0.01
1.2
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
485
4857
0.99
0.00
4.4
4.4
mmol/l
4.3
4.5
3.49
439
4473
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
154
1.04
0.00
1.6
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
115
0.96
0.00
1.5
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
135
0.96
0.00
1.1
1.3
u/l
8.7
7.6
—
8
105
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
137
1.02
0.00
1.0
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
10
98
1.02
0.00
1.4
1.4
u/ml
118.6
143.0
—
5
22
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
151
0.99
0.00
1.7
2.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
496
4961
1.00
0.00
5.0
4.9
mmol/l
2.5
2.7
3.87
443
4522
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
52
0.96
0.00
2.0
2.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
51
0.98
0.00
1.2
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
49
1.02
0.00
1.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
65
0.92
0.00
1.2
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
77.8
—
0
9
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.7
—
0
6
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
21.5
—
0
8
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_HYPOTHERMIA – Hypothermia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).